ICU Medical, Inc. $ICUI Shares Acquired by Dynamic Technology Lab Private Ltd

Key Points

• Dynamic Technology Lab Private Ltd increased its stake in ICU Medical, Inc. by 855.9%, acquiring an additional 11,127 shares during the first quarter, bringing its total ownership to 12,427 shares valued at approximately $1.7 million.
• Other significant investors, such as The Manufacturers Life Insurance Company and GAMMA Investing LLC, also dramatically increased their positions in ICU Medical, showcasing strong institutional interest.
• ICU Medical recently reported earnings of $2.10 per share for the latest quarter, exceeding estimates, but showed a year-over-year revenue decline of 8.0%.

Dynamic Technology Lab Private Ltd increased its position in shares of ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 855.9% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 12,427 shares of the medical instruments supplier's stock after acquiring an additional 11,127 shares during the period. Dynamic Technology Lab Private Ltd owned about 0.05% of ICU Medical worth $1,726,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of the business. Algert Global LLC boosted its position in ICU Medical by 16.9% during the fourth quarter. Algert Global LLC now owns 6,370 shares of the medical instruments supplier's stock valued at $988,000 after acquiring an additional 920 shares during the last quarter. Deutsche Bank AG lifted its position in shares of ICU Medical by 41.1% during the 4th quarter. Deutsche Bank AG now owns 21,792 shares of the medical instruments supplier's stock valued at $3,381,000 after buying an additional 6,345 shares during the last quarter. FORA Capital LLC bought a new position in shares of ICU Medical during the 4th quarter worth $488,000. Gotham Asset Management LLC grew its stake in shares of ICU Medical by 22.3% during the 4th quarter. Gotham Asset Management LLC now owns 40,610 shares of the medical instruments supplier's stock worth $6,301,000 after acquiring an additional 7,410 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in ICU Medical by 4.1% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 12,204 shares of the medical instruments supplier's stock worth $1,894,000 after acquiring an additional 478 shares during the last quarter. Institutional investors own 96.10% of the company's stock.

ICU Medical Stock Up 2.3%

NASDAQ:ICUI traded up $3.00 during midday trading on Wednesday, reaching $133.57. 351,287 shares of the stock traded hands, compared to its average volume of 296,714. The stock has a market capitalization of $3.30 billion, a PE ratio of 21.94 and a beta of 0.86. ICU Medical, Inc. has a 12-month low of $107.00 and a 12-month high of $196.26. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.17 and a current ratio of 2.44. The business has a 50-day moving average of $126.39 and a two-hundred day moving average of $134.20.

ICU Medical (NASDAQ:ICUI - Get Free Report) last announced its quarterly earnings data on Thursday, August 7th. The medical instruments supplier reported $2.10 earnings per share for the quarter, beating analysts' consensus estimates of $1.44 by $0.66. ICU Medical had a negative net margin of 1.56% and a positive return on equity of 7.24%. The firm had revenue of $543.57 million for the quarter, compared to analyst estimates of $543.33 million. During the same period in the previous year, the company earned $1.56 earnings per share. The business's quarterly revenue was down 8.0% compared to the same quarter last year. ICU Medical has set its FY 2025 guidance at 6.850-7.15 EPS. On average, equities analysts forecast that ICU Medical, Inc. will post 4.11 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have weighed in on ICUI shares. Wall Street Zen upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a research report on Friday, September 5th. Piper Sandler raised their price target on ICU Medical from $145.00 to $153.00 and gave the stock an "overweight" rating in a research note on Wednesday. Finally, Raymond James Financial dropped their target price on ICU Medical from $187.00 to $180.00 and set a "strong-buy" rating on the stock in a report on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has given a Hold rating to the company's stock. According to MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus price target of $181.00.

Insider Activity

In other ICU Medical news, Director David C. Greenberg purchased 1,200 shares of ICU Medical stock in a transaction that occurred on Wednesday, August 27th. The stock was bought at an average price of $126.42 per share, with a total value of $151,704.00. Following the acquisition, the director owned 7,960 shares of the company's stock, valued at $1,006,303.20. This trade represents a 17.75% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Vivek Jain acquired 21,929 shares of the firm's stock in a transaction on Thursday, August 14th. The shares were bought at an average cost of $112.84 per share, for a total transaction of $2,474,468.36. Following the completion of the acquisition, the chief executive officer owned 130,149 shares of the company's stock, valued at approximately $14,686,013.16. This represents a 20.26% increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.50% of the stock is owned by insiders.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.